Giovanni Mariggi

Life Sciences Investing at @Medicxi

[Jim Huntington @JHuntingtonUCam]

#ZFactor is pleased to announce the successful FTIH dosing of ZF874! https://t.co/hHoZKDtHHa @alpha1uk @AlphaFriend @Alpha1_Global Shout out to members of my lab @TheCIMR, co-founder @sciencescanner and @UCamEnterprise @ChrisM_Chem @Medicxi @RxCelerate @RxChemistry @TrevorBaglin

[Giovanni Mariggi @GMariggi]

@michael_gilman Wise words

[Jim Huntington @JHuntingtonUCam]

Congrats to the team at Z Factor! Today we officially nominated a DC after four years of hard work! It's an orally available, Z-specific folding corrector for alpha-1-antitrypsin deficiency @Alpha1_Global @AlphaFriend #COPD Gearing up for the clinic! https://t.co/lLAUQhzNH6

[Foundation Institute for 21st Century Medicine @C21med]

First day on the job for our Co-Founder Richard Mason. Welcome Richard - its going to be an exciting ride!

[Medicxi @medicxi]

Congrats to @medicxi's Moncef Slaoui on being included in the Medicine Maker's Top 100 Power List 2018! #2018PowerList https://t.co/f7w98V1FXs

[Medicxi @medicxi]

Excited to announce the launch of The Foundation Institute, an ‘ideas factory’ to translate the best science into novel drugs candidates and new biotech companies. Co-founded by @medicxi @sciencescanner @richardcmason #dreamteam #medicximilestone https://t.co/NKrQ5afXR5

[Medicxi @medicxi]

We're also thrilled to announce our new @medicxi Operating Partner....Richard Lee #MedicxiMilestone #GrowYourOwn
Blogpost by @fderubertis
https://t.co/JwY2vhgrmN

[Medicxi @medicxi]

Today is #RareDiseaseDay! A big thanks to the teams @medicxi portfolio companies @GenSightBio, @ImpactBioMed, Z-Factor, ApcinteX, Palladio Biosciences, Kaerus Biosciences, Morphogen-IX for all their hard work and dedication

[Medicxi @medicxi]

Congratulations to Remy at the team at $NERV on starting Ph2b dosing for their MIN-202 program in insomnia https://t.co/coLE7dMVEV

[Medicxi @medicxi]

We’re delighted to have @fderubertis recognised as one of the 2017 #Bloomberg50, which celebrates leaders who have quantifiably changed the landscape of global business this year. https://t.co/aFyMVTTboH

[Critical Pressure @crit_pressure]

Excited to announce the launch of @crit_pressure with support of a £10m investment from @medicxi. Tackling septic shock with novel vasopressor therapies.

[Medicxi @medicxi]

Congratulations to Acutus Medical on FDA clearance for AcQMap™ 3D mapping for complex arrhythmias: https://t.co/5jwezVmVmM Ground-breaking

[Medicxi @medicxi]

Impact is reviving fedratanib, acquired by $SNY from TargeGen in 2013, but subsequently discontinued in 2013 when FDA issued clinical hold

[Jon @J_S_Edwards]

Really excited to be about of this. Bringing a much needed, and best in class, medicine to MF patients https://t.co/Q8aDbmfcdj

[John Carroll @JohnCendpts]

Four years after it imploded at Sanofi, John Hood is resurrecting the myelofibrosis drug fedratinib
https://t.co/73GauGp521

[Medicxi @medicxi]

Gadeta welcomes Shelley Margetson as CEO & strengthens management team to push gamma-delta T cell tech into clinic: https://t.co/Yl2Lm2FueL

[Medicxi @medicxi]

STATs are another poster-child for the “no target is undruggable” mantra - and Janpix were the first to crack them

[Francesco DeRubertis @fderubertis]

Super excited to announce that moncef slaoui, one of the top #pharma #R&D leaders, is joining #medicxi

[Labiotech.eu @Labiotech_eu]

Discussing the #Virtual #Biotech Model with XO1 Co-Founder Trevor Baglin https://t.co/TkZ0Lt9hyy #Academic #entrepreneur #Cambridge #EU

[One Nucleus @OneNucleus]

Great week for the sector. Welcoming @lifearc1 & their £500M fund & congrats to @medicxi for the $300M late stage fund. Have a good weekend!